Opaleye Management Inc., Ten Percent Owner at Grace Therapeutics, holds 2.78M shares in Grace Therapeutics (Ticker: GRCE), holds 551.88K shares in Sol-Gel Technologies (Ticker: SLGL), holds 3.15M shares in Alpha Cognition Inc (Ticker: ACOG). Most recently, Opaleye Management Inc. Bought ― shares of Grace Therapeutics on Sep 10, 2026 for an estimated value of $31.77K.
What was Opaleye Management Inc.’s latest transaction?
Opaleye Management Inc. latest transaction was an Informative Buy of $31.77K.
What was Opaleye Management Inc.'s most profitable transaction?
Opaleye Management Inc.’s most profitable transaction was an Informative Buy of OCUL stock on January 2, 2020. The return on the trade was 424.00%.
What is Opaleye Management Inc.'s role in Grace Therapeutics?
Opaleye Management Inc.'s role in Grace Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.